Wednesday February 10 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Gastrointestinal Stromal Tumor GIST News and Headlines
Gastrointestinal Stromal Tumor GIST News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Gastrointestinal Stromal Tumor GIST
news alerts.
Site Map > Biotechnology News > Health News > Gastrointestinal Stromal Tumor GIST
.

Comparison of Two Doses of Imatinib for the Treatment of Unresectable or Metastatic Gastrointestinal Stromal T
Journal of Clinical Oncology:  similar ...
Data Show Progression-Free Survival Advantage With Sutent In Patients With Pancreatic Neuroendocrine Tumors
Pharma Live:  similar ...
Pfizer's new pipeline shows growth and diversity in research and development
News-Medical.Net:  similar ...
Patients with rare cancer get a second chance to fight back
Individual.com:  similar ...
New Data Show Progression-Free Survival Advantage with Sutent (sunitinib) vs Placebo in Patients with Pancreat
PharmiWeb:  similar ...
New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas
FinanzNachrichten.de:  similar ...
Pfizer: Data Show Progression-Free Survival Advantage with Sutent...
Zibb:  similar ...
Early action against rare cancer reduces relapse risk
Pharma Live:  similar ...
Data Show Progression-Free Survival Advantage With Sutent In Patients With Pancreatic Neuroendocrine Tumors
PharmiWeb:  similar ...
Pfizer to seek expanded indication for Sutent for pancreatic cancer
HemOnc Town:  similar ...
Sutent Delays Progression of Pancreatic Neuroendocrine Tumors
Cancer Consultants:  similar ...
Early action against rare cancer reduces relapse risk - Zibb.com
Zibb:  similar ...
Early action against rare cancer reduces relapse risk
Therapeutics Daily:  similar ...
Early action against rare cancer reduces relapse risk
Canada NewsWire:  similar ...
Early action against rare cancer reduces relapse risk
Individual.com:  similar ...
University of Pittsburgh Schools of the Health Sciences: Drug shows promise as new treatment for gut tumor
NewsRX:  similar ...
Data Show Progression-Free Survival Advantage With Sutent(R) In Patients With Pancreatic Neuroendocrine Tumors
Medical News Today:  similar ...
Pfizer's Sutent shows progress-free survival in patients with pancreatic neuroendocrine tumors
Pharma Letter:  similar ...
Pfizer's phase 3 trial of Sutent in pancreatic neuroendocrine tumours shows progression-free survival advantag
PharmaBiz:  similar ...
IPI-504 Fails to Improve Outcomes for Patients With GIST Refractory to TKIs: Presented at ASCO-GI
Doctors Guide:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.